Letter by Hjemdahl et al Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”-Reference-Cited by-同舟云学术

Letter by Hjemdahl et al Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”

Published:2013-03-19 Issue:11 Volume:127 Page:
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hjemdahl Paul¹,Johnsson Hans²,Wallén N. Håkan³

Affiliation:

1. Department of Medicine SolnaClinical Pharmacology UnitKarolinska Institutet and Karolinska University Hospital (Solna)Stockholm, Sweden

2. Department of Emergency MedicineKarolinska Institutet and Karolinska University Hospital (Solna)Stockholm, Sweden

3. Department of Clinical Sciences and Cardiology ClinicKarolinska Institutet and Danderyd University HospitalStockholm, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

2. Bleeding Risk with Dabigatran in the Frail Elderly

3. New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation

4. Monitoring new oral anticoagulants, managing thrombosis, or both?

5. Impact of dabigatran on a large panel of routine or specific coagulation assays

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of dabigatran plasma concentrations in the perioperative setting;Thrombosis and Haemostasis;2015-07